Skip to main content
Log in

Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons?

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. E. Gregoric, J.A. Gregoric, F. Guarneri, S. Benvenga, Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine 39, 41–47 (2011)

    Article  PubMed  CAS  Google Scholar 

  2. B.Z. Dolimbek, K.R. Aoki, L.E. Steward, J. Jankovic, M.Z. Atassi, Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol. Immunol. 44, 1029–1041 (2007)

    Article  PubMed  CAS  Google Scholar 

  3. M.Z. Atassi, B.Z. Dolimbek, J. Jankovic, L.E. Steward, K.R. Aoki, Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies, Immunobiology. (2011). doi:10.1016/j.imbio.2010.12.009

  4. Center for Drug Evaluation and Research, Summary review for regulatory action. Application Number 125274. (2009), http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/125274s000_SumR.pdf. Accessed 24 Mar 2009

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Zouhair Atassi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atassi, M.Z., Deitiker, P.R. Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons?. Endocrine 40, 140–141 (2011). https://doi.org/10.1007/s12020-011-9481-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-011-9481-2

Keywords

Navigation